Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Munich - Delayed Quote EUR

Ono Pharmaceutical Co., Ltd. (ON4.MU)

Compare
9.40
-0.10
(-1.05%)
At close: April 4 at 5:25:46 PM GMT+2
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
502,672,000
502,672,000
447,187,000
361,361,000
309,284,000
Cost of Revenue
127,126,000
127,126,000
110,062,000
93,511,000
85,573,000
Gross Profit
375,547,000
375,547,000
337,124,000
267,850,000
223,711,000
Operating Expense
215,611,000
215,611,000
195,161,000
164,654,000
125,381,000
Operating Income
159,936,000
159,936,000
141,963,000
103,196,000
98,330,000
Net Non Operating Interest Income Expense
3,798,000
3,798,000
1,565,000
1,836,000
2,556,000
Pretax Income
163,734,000
163,734,000
143,532,000
105,025,000
100,890,000
Tax Provision
35,694,000
35,694,000
30,619,000
24,340,000
25,392,000
Net Income Common Stockholders
127,977,000
127,977,000
112,723,000
80,519,000
75,425,000
Diluted NI Available to Com Stockholders
127,977,000
127,977,000
112,723,000
80,519,000
75,425,000
Basic EPS
266.61
266.61
230.85
162.19
151.11
Diluted EPS
266.57
266.57
230.79
162.16
151.09
Basic Average Shares
480,009.02
480,009.02
488,300.45
496,459
499,137
Diluted Average Shares
480,039
480,039
488,353
496,527
499,203
Total Operating Income as Reported
159,935,000
159,935,000
141,963,000
103,195,000
98,330,000
Total Expenses
342,737,000
342,737,000
305,223,000
258,165,000
210,954,000
Net Income from Continuing & Discontinued Operation
127,977,000
127,977,000
112,723,000
80,519,000
75,425,000
Normalized Income
127,977,000
127,977,000
112,723,000
80,519,000
75,425,000
Interest Income
4,027,000
4,027,000
2,478,000
2,710,000
2,693,000
Interest Expense
229,000
229,000
913,000
874,000
137,000
Net Interest Income
3,798,000
3,798,000
1,565,000
1,836,000
2,556,000
EBIT
163,963,000
163,963,000
144,445,000
105,899,000
101,027,000
EBITDA
182,103,000
182,103,000
161,896,000
123,620,000
116,847,000
Reconciled Cost of Revenue
127,126,000
127,126,000
110,062,000
93,511,000
85,573,000
Reconciled Depreciation
18,140,000
18,140,000
17,451,000
17,721,000
15,820,000
Net Income from Continuing Operation Net Minority Interest
127,977,000
127,977,000
112,723,000
80,519,000
75,425,000
Normalized EBITDA
182,103,000
182,103,000
161,896,000
123,620,000
116,847,000
Tax Rate for Calcs
0
0
0
0
0
3/31/2021 - 5/24/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade